It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CHE’s FA Score shows that 1 FA rating(s) are green whileLTGHF’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CHE’s TA Score shows that 6 TA indicator(s) are bullish.
CHE (@Medical/Nursing Services) experienced а +0.27% price change this week, while LTGHF (@Medical/Nursing Services) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.49%. For the same industry, the average monthly price growth was -2.00%, and the average quarterly price growth was +1671.30%.
CHE is expected to report earnings on Feb 25, 2025.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
CHE | LTGHF | CHE / LTGHF | |
Capitalization | 9.7B | 1.31B | 744% |
EBITDA | 414M | 2.96B | 14% |
Gain YTD | -3.366 | -46.393 | 7% |
P/E Ratio | 35.73 | 20.17 | 177% |
Revenue | 2.26B | 27.4B | 8% |
Total Cash | 264M | 1.15B | 23% |
Total Debt | 155M | 12.1B | 1% |
CHE | LTGHF | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 69 | 41 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 81 Overvalued | 2 Undervalued | |
PROFIT vs RISK RATING 1..100 | 31 | 100 | |
SMR RATING 1..100 | 36 | 97 | |
PRICE GROWTH RATING 1..100 | 72 | 73 | |
P/E GROWTH RATING 1..100 | 84 | 95 | |
SEASONALITY SCORE 1..100 | 50 | 30 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LTGHF's Valuation (2) in the null industry is significantly better than the same rating for CHE (81) in the Medical Or Nursing Services industry. This means that LTGHF’s stock grew significantly faster than CHE’s over the last 12 months.
CHE's Profit vs Risk Rating (31) in the Medical Or Nursing Services industry is significantly better than the same rating for LTGHF (100) in the null industry. This means that CHE’s stock grew significantly faster than LTGHF’s over the last 12 months.
CHE's SMR Rating (36) in the Medical Or Nursing Services industry is somewhat better than the same rating for LTGHF (97) in the null industry. This means that CHE’s stock grew somewhat faster than LTGHF’s over the last 12 months.
CHE's Price Growth Rating (72) in the Medical Or Nursing Services industry is in the same range as LTGHF (73) in the null industry. This means that CHE’s stock grew similarly to LTGHF’s over the last 12 months.
CHE's P/E Growth Rating (84) in the Medical Or Nursing Services industry is in the same range as LTGHF (95) in the null industry. This means that CHE’s stock grew similarly to LTGHF’s over the last 12 months.
CHE | |
---|---|
RSI ODDS (%) | 2 days ago78% |
Stochastic ODDS (%) | 2 days ago51% |
Momentum ODDS (%) | 2 days ago63% |
MACD ODDS (%) | 2 days ago49% |
TrendWeek ODDS (%) | 2 days ago57% |
TrendMonth ODDS (%) | 2 days ago42% |
Advances ODDS (%) | 2 days ago56% |
Declines ODDS (%) | 4 days ago47% |
BollingerBands ODDS (%) | 2 days ago67% |
Aroon ODDS (%) | 4 days ago40% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IVGSX | 23.71 | 0.24 | +1.02% |
VY® Invesco Growth and Income S | |||
MUECX | 36.44 | 0.23 | +0.64% |
MFS Blended Research Core Equity C | |||
GCSLX | 19.28 | N/A | N/A |
Pioneer Global Sustainable Equity C | |||
GEMOX | 12.26 | N/A | N/A |
Goldman Sachs Emerging Mkt Eq ex. ChnInv | |||
MKVCX | 13.91 | -0.01 | -0.07% |
MFS International Large Cap Value C |
A.I.dvisor indicates that over the last year, CHE has been loosely correlated with UHS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CHE jumps, then UHS could also see price increases.
Ticker / NAME | Correlation To CHE | 1D Price Change % | ||
---|---|---|---|---|
CHE | 100% | +1.88% | ||
UHS - CHE | 36% Loosely correlated | +0.05% | ||
LTGHF - CHE | 32% Poorly correlated | N/A | ||
HCA - CHE | 32% Poorly correlated | -0.23% | ||
NHC - CHE | 30% Poorly correlated | +2.04% | ||
ENSG - CHE | 29% Poorly correlated | +1.86% | ||
More |
A.I.dvisor tells us that LTGHF and CHE have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LTGHF and CHE's prices will move in lockstep.
Ticker / NAME | Correlation To LTGHF | 1D Price Change % | ||
---|---|---|---|---|
LTGHF | 100% | N/A | ||
CHE - LTGHF | 29% Poorly correlated | +1.88% | ||
INNV - LTGHF | 10% Poorly correlated | -1.49% | ||
AVAH - LTGHF | 7% Poorly correlated | +0.52% | ||
AGL - LTGHF | 5% Poorly correlated | +6.59% | ||
LFST - LTGHF | 0% Poorly correlated | +1.25% | ||
More |